AUS Edition 
NZ Edition 
UK Edition 
CA Edition 
USA Edition 
FRA Edition 
GER Edition 
ESP Edition 
ITA Edition 
NLD Edition 
PRT Edition 
SWE Edition 
GRC Edition 
IND Edition 
POL Edition 
BRA Edition 
ZAF Edition 
RUS Edition 
CHN Edition 
UAE Edition 
⚠
✓
Quipt Home Medical Corp (NASDAQ:QIPT)
1.78 USD
0.000 0.000%Sponsored Reports
Loading...
| Previous Close (in USD) | 1.78 |
|---|---|
| Change | 0.000 0.000% |
| 52 W H/L (in USD) | 4.070/1.350 |
| EBITDA (in USD) | 43.749M |
| PE Ratio | -- |
| Volume | 110105 |
| Diluted Eps TTM | -0.21 |
| Total Assets (in USD) | 246.857M |
|---|---|
| Total Liabilities (in USD) | 140.057M |
| Revenue TTM (in USD) | 240.848M |
| Cash (in USD) | 16.174M |
| Market Cap (in USD) | 61.256 M |
| Revenue Per Share TTM | 5.602 |
| Gross Profit TTM (in USD) | 173.587M |
Summary
Income Statement
Balance Sheet
Change in Cash
Operating Cash
Quipt Home Medical Corp
Quipt Home Medical Corp., through its subsidiaries, engages in the provision of durable and home medical equipment and supplies in the United States. The company offers nebulizers; invasive ventilation; and home medical equipment, such as stair lifts, ramps, bath safety equipment, daily living, and ambulatory, as well as home modification solutions. It also engages in the rental and sale of medical equipment and related devices. In addition, the company offers solutions that supports patients dealing with heart and pulmonary disease, sleep apnea, reduced mobility, COPD, neuromuscular disorders, obesity, and other chronic health conditions. The company was formerly known as Protech Home Medical Corp. and changed its name to Quipt Home Medical Corp. in May 2021. Quipt Home Medical Corp. is headquartered in Wilder, Kentucky.
Employees: 1200
Key Executives
| Sr. No. | Name | Title | Year Born |
|---|---|---|---|
| 1. | Mr. Gregory J. Crawford | Chairman, Pres & CEO | NA |
| 2. | Mr. Hardik Mehta | Chief Financial Officer | NA |
| 3. | Mr. Jerry Kirn | VP of Operations | NA |
| 4. | Mr. David Bachelder | Exec. VP of Operations | NA |
| 5. | Mr. William Todd Zehnder | Chief Strategy Officer & Investor Relations | 1975 |
| 6. | Cole Stevens | VP of Corp. Devel. & VP of Investor Relations | NA |
| 7. | Leslie Becker | Exec. VP of Bus. Devel. | NA |
| 8. | Dr. William Dana Frazier M.D. | Chief Medical Officer | 1958 |
| 9. | Mr. Mark Miles | VP of Information Technology | NA |
| 10. | Mr. Thomas W. Roehrig | Exec. VP of Fin. | 1966 |
Peers
Sector: Healthcare
Industry: Medical Distribution
| Company | Change (USD) | Price (USD) | Trailing PE(x) | Forward PE(x) | Price Sales TTM(x) | Price to Book Value(x) | Enterprise Value to Revenue(x) | Enterprise Value to EBITDA(x) |
|
MCK
McKesson Corporation |
+13.850 1.963% | 707.98 | 17.950 | 14.535 | 0.204 | 5.043 | 0.220 | 12.174 |
|
COR
Cencora Inc. |
+5.060 1.738% | 292.52 | 23.390 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 |
|
CAH
Cardinal Health Inc |
+2.950 1.821% | 161.8 | 166.110 | 14.706 | 0.116 | 16.066 | 0.120 | 19.776 |
|
HSIC
Henry Schein Inc |
+0.190 0.255% | 74.5 | 24.120 | 14.045 | 0.739 | 2.496 | 0.948 | 13.334 |
Income Statement
(Currency in USD)| Breakdown | 30-09-2023 | 30-09-2022 | 30-09-2021 | 30-09-2020 | 30-09-2019 |
|---|---|---|---|---|---|
| Income Before Tax | -2.699M | 2.212M | -9.329M | -4.053M | -6.702M |
| Minority Interest | - | - | - | - | - |
| Net Income | -2.784M | 4.839M | -6.174M | -4.181M | -6.905M |
| Selling General Administrative | 5.28M | 5.493M | 47.374M | 32.08M | 28.959M |
| Gross Profit | 163.845M | 106.649M | 74.179M | 52.989M | 43.39M |
| Reconciled Depreciation | 40.163M | 23.04M | 17.786M | 14.616M | 10.552M |
| Ebit | 15.089M | 17.356M | 2.905M | 4.491M | 2.829M |
| Ebitda | 55.252M | 40.396M | 20.691M | 19.107M | 13.381M |
| Depreciation And Amortization | 40.163M | 23.04M | 17.786M | 14.616M | 10.552M |
| Operating Income | 15.089M | 17.356M | 2.905M | 4.491M | 2.829M |
| Other Operating Expenses | 206.564M | 122.064M | 95.715M | 67.188M | 57.812M |
| Interest Expense | 6.607M | 2.079M | 1.853M | 1.853M | 1.922M |
| Tax Provision | 0.085M | -1.904M | -3.155M | 0.128M | 0.203M |
| Interest Income | - | - | - | 0M | 0.026M |
| Net Interest Income | -6.607M | -2.079M | -1.993M | -2.065M | -3.224M |
| Income Tax Expense | 0.085M | -1.904M | -3.155M | 0.128M | 0.203M |
| Total Revenue | 221.742M | 139.862M | 102.351M | 73.03M | 61.163M |
| Total Operating Expenses | 148.667M | 88.851M | 67.543M | 47.147M | 40.04M |
| Cost Of Revenue | 57.897M | 33.213M | 28.172M | 20.041M | 17.772M |
| Total Other Income Expense Net | -11.27M | -15.144M | -12.234M | -8.544M | -9.531M |
| Net Income From Continuing Ops | -2.784M | 4.839M | -6.174M | -4.181M | -6.905M |
| Net Income Applicable To Common Shares | - | 4.839M | -6.174M | -6.755M | -7.386M |
Balance Sheet
(Currency in USD)| Breakdown | 30-09-2024 | 30-09-2023 | 30-09-2022 | 30-09-2021 | 30-09-2020 |
|---|---|---|---|---|---|
| Total Assets | 246.857M | 247.408M | 132.214M | 108.573M | 71.82M |
| Intangible Assets | 67.953M | - | 28.887M | 14.874M | 5.56M |
| Other Current Assets | 6.911M | - | 1.052M | 1.43M | 0.55M |
| Total Liab | 140.057M | 136.293M | 52.667M | 49.951M | 43.677M |
| Total Stockholder Equity | 107.191M | 111.115M | 79.547M | 58.622M | 28.143M |
| Other Current Liab | 6.053M | - | -18.67M | 5.585M | 6.178M |
| Common Stock | - | - | 214.254M | 202.827M | 167.771M |
| Capital Stock | 0M | - | 214.254M | 202.827M | 167.771M |
| Retained Earnings | -170.571M | - | -161.024M | -165.863M | -165.924M |
| Good Will | 50.733M | - | 28.208M | 12.456M | 3.881M |
| Other Assets | -0.115M | - | 0.086M | 0.504M | 0.856M |
| Cash | 16.174M | 17.209M | 8.516M | 34.612M | 29.125M |
| Cash And Equivalents | - | - | - | - | - |
| Total Current Liabilities | 60.85M | 60.574M | 41.74M | 32.737M | 24.299M |
| Current Deferred Revenue | 3.568M | - | 3.036M | 7.337M | 4.386M |
| Net Debt | 83.628M | -17.209M | 18.045M | -7.558M | -6.26M |
| Short Term Debt | 21.919M | - | 15.634M | 9.973M | 6.326M |
| Short Long Term Debt | 16.052M | - | 12.33M | 6.992M | 4.296M |
| Short Long Term Debt Total | 99.802M | - | 26.561M | 27.054M | 22.865M |
| Other Stockholder Equity | 277.762M | - | 26.317M | 21.658M | 16.324M |
| Property Plant Equipment | - | - | 33.497M | 23.506M | 22.24M |
| Total Current Assets | 73.054M | 65.433M | 41.536M | 57.233M | 45.125M |
| Long Term Investments | 1.311M | - | - | - | - |
| Short Term Investments | - | - | - | - | - |
| Net Receivables | 29.116M | 48.224M | 16.383M | 11.938M | 9.058M |
| Long Term Debt | 64.6M | - | 3.732M | 12.297M | 13.32M |
| Inventory | 20.853M | - | 15.585M | 9.253M | 6.392M |
| Accounts Payable | 29.31M | 60.574M | 41.74M | 9.842M | 7.409M |
| Accumulated Other Comprehensive Income | - | - | - | - | 9.973M |
| Non Currrent Assets Other | 0.062M | 128.57M | 0.086M | 0.504M | 0.639M |
| Non Current Assets Total | 173.919M | 181.975M | 90.678M | 51.34M | 26.695M |
| Capital Lease Obligations | 19.15M | - | 10.499M | 7.765M | 5.248M |
| Long Term Debt Total | - | - | - | - | - |
Cash Flow
(Currency in USD)| Breakdown | 30-09-2023 | 30-09-2022 | 30-09-2021 | 30-09-2020 | 30-09-2019 |
|---|---|---|---|---|---|
| Investments | -82.825M | -42.493M | -17.838M | -7.897M | 1.767M |
| Total Cashflows From Investing Activities | - | -42.493M | -17.838M | -10.57M | 3.937M |
| Total Cash From Financing Activities | 50.874M | -9.851M | 3.91M | 13.952M | -3.822M |
| Net Income | -2.784M | 4.839M | -6.174M | -5.046M | -5.579M |
| Change In Cash | 8.693M | -26.096M | 5.385M | 19.521M | 6.439M |
| Begin Period Cash Flow | 8.516M | 34.612M | 29.227M | 9.604M | 3.272M |
| End Period Cash Flow | 17.209M | 8.516M | 34.612M | 29.125M | 9.711M |
| Total Cash From Operating Activities | 40.536M | 26.344M | 18.692M | 13.172M | 8.39M |
| Depreciation | - | 23.04M | 17.786M | 14.616M | 10.552M |
| Other Cashflows From Investing Activities | - | - | - | - | 4.454M |
| Dividends Paid | - | - | - | - | - |
| Change To Inventory | - | -2.419M | -0.044M | -1.771M | 0.638M |
| Sale Purchase Of Stock | - | - | - | - | - |
| Other Cashflows From Financing Activities | 63.419M | 10.788M | 17.803M | 7.543M | 9.906M |
| Capital Expenditures | 6.787M | 8.968M | 5.046M | 0.092M | 1.362M |
| Change In Working Capital | -1.949M | 0.758M | -8.876M | -4.661M | -3.822M |
| Other Non Cash Items | 45.269M | -5.882M | 14.804M | 1.49M | 1.385M |
| Free Cash Flow | 33.749M | 17.376M | 13.646M | 13.08M | 7.028M |
Funds
| Sr. No. | Name | Purchased On | Shares |
|---|---|---|---|
| 1. | Philotimo Focused Growth and Income | 3 months ago | 1655011 |
| 2. | Royce Small-Cap Opportunity Invmt | 3 months ago | 1037695 |
| 3. | iShares Russell 2000 ETF | 2 months ago | 912379 |
| 4. | FTGF RY US SmCp Opp A USD Dis(A) | 2 months ago | 826129 |
| 5. | Putnam Small Cap Value Managed Account | 3 months ago | 499600 |
| 6. | Putnam U.S. Small Cap Value Equity | 3 months ago | 499600 |
| 7. | Putnam Small Cap Value A | 3 months ago | 499600 |
| 8. | Fidelity Small Cap Index | 4 months ago | 400414 |
| 9. | Kennedy Micro Cap | 3 months ago | 348208 |
| 10. | Russell Inv US Small Cap Equity Y | 2 months ago | 302546 |
| 11. | iShares Russell 2000 Value ETF | 2 months ago | 283795 |
| 12. | Dunham Small Cap Value N | 3 months ago | 220460 |
| 13. | State St Russell Sm/Mid Cp® Indx SL Cl I | 2 months ago | 217632 |
| 14. | Putnam VT Small Cap Value IA | 3 months ago | 203900 |
| 15. | WPG Partners Micro Cap Opportunities | 3 months ago | 196552 |
| 16. | Vanguard Russell 2000 ETF | 2 months ago | 186013 |
| 17. | Russell Inv Small Cap Fund F | 2 months ago | 153122 |
| 18. | Perritt MicroCap Opportunities Investor | 3 months ago | 142500 |
| 19. | State St Russell Sm Cap® Indx SL Cl I | 2 months ago | 135000 |
| 20. | Russell Inv US Small Cap Equity | 2 months ago | 96654 |
Institutions
| Sr. No. | Name | Purchased On | Shares |
|---|---|---|---|
| 1. | Kennedy Capital Management Inc | 3 months ago | 348208 |
| 2. | Northern Trust Corp | 6 months ago | 257402 |
| 3. | Morgan Stanley - Brokerage Accounts | 6 months ago | 249644 |
| 4. | Renaissance Technologies Corp | 3 months ago | 244600 |
| 5. | Vanguard Group Inc | 3 months ago | 222092 |
| 6. | Boston Partners Global Investors, Inc | 3 months ago | 220460 |
| 7. | BB&T Corp. | 6 months ago | 200000 |
| 8. | Jb Capital Partners LP | 6 months ago | 200000 |
| 9. | Perritt Capital Management Inc. | 6 months ago | 190400 |
| 10. | Claret Asset Management Corporation | 3 months ago | 4390212 |
| 11. | Forager Capital Management, LLC | 3 months ago | 4199562 |
| 12. | Kanen Wealth Management LLC | 3 months ago | 2969541 |
| 13. | BlackRock Inc | 3 months ago | 1993463 |
| 14. | Royce & Associates, LP | 3 months ago | 1949989 |
| 15. | First Manhattan Co. LLC | 6 months ago | 1650000 |
| 16. | Acadian Asset Management LLC | 3 months ago | 969822 |
| 17. | Franklin Resources Inc | 3 months ago | 705792 |
| 18. | State Street Corp | 3 months ago | 635400 |
| 19. | Geode Capital Management, LLC | 6 months ago | 512304 |
| 20. | Arrowstreet Capital Limited Partnership | 6 months ago | 493858 |
Data Powered by EOD Historical Data (“EODHD”). All CFDs (stocks, indices, mutual funds, ETFs), and Forex are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. EODHD is not using exchanges data feeds for the pricing data, EODHD is using OTC, peer to peertrades and trading platforms over 100+ sources, EODHD is aggregating its data feeds via VWAP method. Therefore, EOD Historical Data doesn’t bear any responsibility for any trading losses you might incur as a result of using this data. EOD Historical Data or anyone involved with EOD Historical Data will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible. EOD Historical Data does not give any warranties (including, without limitation, as to merchantability or fitness for a particular purpose or use).
Sponsored Articles
Loading...
Related Articles
Loading...